Topic: Cardiovascular

Samuel Montgomery, a cardiovascular specialist, and Steve Slocum are knighted as "Red Knights" of the No Agenda Round Table. Montgomery's donation was accompanied by a discussion of cardiac catheterization procedures, while Slocum, a VA healthcare worker, shared his firsthand experiences with the discrepancies in COVID-19 messaging within government medical facilities. Both contributed via Bitcoin to support the show.

The American Academy of Sleep Medicine and other health organizations are advocating for the elimination of seasonal time changes in favor of permanent standard time. Experts suggest that morning light is essential for mood regulation and internal clock alignment, whereas poor sleep from time shifts contributes to obesity, diabetes, and anxiety. Recommendations for managing the transition include maintaining a seven-hour sleep schedule and seeking immediate morning sunlight.

Recent health alerts from Newsweek and the Mayo Clinic link the sugar substitute Xylitol and energy drinks to sudden cardiac arrest. A study of 144 survivors found that several had consumed energy drinks shortly before their cardiac events. The hosts express skepticism toward these findings, questioning why Xylitol—which has been in use for decades—is only now being blamed for a surge in heart issues.

Goldman Sachs predicts that 15 million U.S. adults will be using weight loss drugs by 2030, especially as they are studied for treating cardiovascular issues and sleep apnea. However, the high cost—often $1,000 a month—remains a barrier, as most insurance companies and Medicare do not currently provide coverage. Some states, including North Carolina, have rolled back coverage due to the extreme budgetary impact.

Former FDA Commissioner Scott Gottlieb discussed the potential for Medicare to cover GLP-1 weight loss drugs like Wegovy and Ozempic. While current law prohibits Medicare from covering drugs solely for weight loss, new clinical data suggests these medications provide significant cardiovascular benefits, which would trigger mandatory coverage. This shift could result in a massive financial boon for pharmaceutical companies as millions of seniors become eligible.

A clinical trial funded by Novo Nordisk found that the drug semaglutide (Wegovy) reduced the risk of heart attacks and strokes by 20% in obese adults without diabetes. The study suggests the drug may have cardio-protective effects beyond simple weight loss, such as reducing inflammation and platelet clumping. Critics point out that the 20% reduction is a relative figure (from 8% to 6.5% in the study group) and note the potential bias in manufacturer-funded research.

Dr. Michael Osterholm discusses new research showing that SARS-CoV-2 can infect white blood cells, leading to an inflammatory response that increases the risk of heart attacks and strokes for up to a year post-infection. The hosts note that this "mechanistic link" confirms what they have been reporting for over a year regarding vascular problems associated with the virus.

Dr. Jen Ashton reported on preliminary data suggesting that the weight loss drug Wegovy may reduce the risk of heart attacks and strokes by 20%. The drug maker plans to seek FDA approval for cardiovascular indications, which could expand insurance coverage. The segment also examines the credentials of the American Board of Obesity Medicine and the societal stigma surrounding medical weight loss interventions.

New data presented at the American College of Cardiology suggests that daily cannabis use increases the risk of coronary artery disease by 34%. Separately, the Cleveland Clinic issued a warning about the sugar substitute erythritol, linking high blood levels of the sweetener to increased risks of heart attack and stroke. The hosts question if these studies are "hit jobs" by competing industries.

Cardiologist Dr. Aseem Malhotra appeared on the BBC to call for the suspension of mRNA vaccine rollouts, citing a link to increased cardiovascular risks. Malhotra referenced peer-reviewed research and the death of his own father to highlight concerns over unexplained excess deaths in the UK. He argued that the risk of serious adverse events, estimated at 1 in 800, outweighs the benefits for many populations given the current variants.

Medical experts from the Cleveland Clinic warned that watching high-stakes sporting events like the World Cup can trigger a fight-or-flight response, potentially straining the cardiovascular system. Individuals with high blood pressure, obesity, or diabetes are at increased risk during these "stress tests." A strategy of "fair weather fandom" is proposed as a health-conscious way to avoid the negative emotional energy of a losing team.

Model Hailey Bieber, 25, was hospitalized after experiencing stroke-like symptoms caused by a small blood clot in her brain. While medical contributors on ABC News suggested a link to prior COVID-19 infections and cardiovascular disease, they avoided discussing potential vaccine side effects. The segment noted an increase in cardiovascular issues among young people and criticized the media for failing to ask logical questions regarding the safety of the vaccines Hailey had received.

Dr. Richard Urso of the Frontline Doctors group argued that hydroxychloroquine is one of the safest drugs in existence, citing its use in treating diabetes, obesity, and cardiovascular issues. He noted its ability to lower hemoglobin A1c and inhibit metastatic colorectal cancer. Urso maintains that the medical community should move past safety concerns given the drug's 65-year history of FDA approval.

New research suggests that prolonged sitting is a distinct health hazard, independent of exercise habits. A news report claims that sitting for just two hours can increase blood sugar and decrease "good" cholesterol. The laundry list of risks includes diabetes, heart disease, and various cancers, leading the hosts to suspect a future pharmaceutical "fix" for sedentary lifestyles.